AIDS education and prevention : official publication of the International Society for AIDS Education · 2026
Building Trust and Engaging Communities for HIV Prevention Research Globally.
СтатьяПоддержка NIH: внешняя программаНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Andrasik Michele, Broder Gail, Louis Kimberly, Baepanye Kagisho, Kamel Luciana, Davis Annet, Segura Patricia, Makhubalo Blossom, Leon Rhandomy Mariadel Rosario, Soler Jorge, Certo Sherri Karas, Gonzalez Rafael, Dawit Waltana, Reinstein Sascha, Shipman Cody E, Seyama Linly, Sanchez Sarmiento Hugo, Mpongo Nombeko Cynthia, Swann Edith, Morar Neetha S
Аннотация
The HIV Vaccine Trials Network (HVTN) is the largest publicly funded international collaboration facilitating the evaluation of vaccines to prevent HIV and TB. Central to the HVTN's success is the reliance on robust community engagement methods, ensuring community participation and facilitating community awareness and knowledge of research. Community engagement is a dynamic process that requires active participation from all stakeholders to ensure success. The HVTN and its global Clinical Research Sites (CRSs) located in Africa, Latin America, and North America are known as the Network. We describe relationships across the Network, specific staff roles and responsibilities, and the myriad activities undertaken to ensure optimal community engagement. Key activities include involving active Community Advisory Boards (CABs), using community consultations, and having trained Community Engagement staff at each CRS. Operating with robust community engagement has resulted in rapid enrollment and high retention of diverse participant populations across Network studies.